Neogen Corporation (NEOG)
NASDAQ: NEOG · Real-Time Price · USD
7.04
+0.06 (0.86%)
At close: Dec 11, 2025, 4:00 PM EST
7.01
-0.03 (-0.43%)
After-hours: Dec 11, 2025, 5:15 PM EST

Neogen Revenue

Neogen had revenue of $209.19M in the quarter ending August 31, 2025, a decrease of -3.58%. This brings the company's revenue in the last twelve months to $886.89M, down -2.77% year-over-year. In the fiscal year ending May 31, 2025, Neogen had annual revenue of $894.66M, down -3.20%.

Revenue (ttm)
$886.89M
Revenue Growth
-2.77%
P/S Ratio
1.71
Revenue / Employee
$298,213
Employees
2,974
Market Cap
1.53B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
May 31, 2025894.66M-29.56M-3.20%
May 31, 2024924.22M101.78M12.37%
May 31, 2023822.45M295.29M56.01%
May 31, 2022527.16M58.70M12.53%
May 31, 2021468.46M50.29M12.03%
May 31, 2020418.17M3.98M0.96%
May 31, 2019414.19M16.26M4.09%
May 31, 2018397.93M39.65M11.07%
May 31, 2017358.28M37.00M11.52%
May 31, 2016321.28M38.20M13.50%
May 31, 2015283.07M35.67M14.42%
May 31, 2014247.41M39.88M19.22%
May 31, 2013207.53M23.48M12.76%
May 31, 2012184.05M11.36M6.58%
May 31, 2011172.68M32.17M22.90%
May 31, 2010140.51M21.79M18.35%
May 31, 2009118.72M16.30M15.92%
May 31, 2008102.42M16.28M18.90%
May 31, 200786.14M13.71M18.92%
May 31, 200672.43M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group435.16B
Johnson & Johnson92.15B
Merck & Co.64.24B
AbbVie59.64B
Eli Lilly and Company59.42B
AstraZeneca58.13B
Novartis AG56.37B
Novo Nordisk49.58B
Revenue Rankings